The Federal Government has announced that it will list new hepatitis C drugs on the Pharmaceutical Benefits Scheme (PBS). The move means that 230,000 hep C sufferers will get access to the new treatment which has a success rate of over 90% with few side effects. Access in Australia will be obtained for the standard PBS co-payment of […]